Patents by Inventor Jennifer E. Bruin

Jennifer E. Bruin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PANCREATIC ENDOCRINE PROGENITOR CELL THERAPIES FOR THE TREATMENT OF OBESITY AND TYPE 2 DIABETES (T2D)
    Publication number: 20210015872
    Abstract: Provided herein are therapies, and methods using that therapy, in the treatment of one or more of Type 2 diabetes (T2D), obesity, glucose intolerance and insulin resistance or to control weight gain in subjects. In particular, the subject may be candidates for treatment with one or more small molecule anti-diabetic drugs and the therapy may include implanting a population of pancreatic endocrine progenitor cells into the subject, where the cells are allowed to mature in vivo to produce a population.
    Type: Application
    Filed: August 3, 2020
    Publication date: January 21, 2021
    Inventors: Timothy J. Kieffer, Jennifer E. Bruin
  • Pancreatic endocrine progenitor cell therapies for the treatment of obesity and type 2 diabetes (T2D)
    Patent number: 10772917
    Abstract: Provided herein are therapies, and methods using that therapy, in the treatment of one or more of Type 2 diabetes (T2D), obesity, glucose intolerance and insulin resistance or to control weight gain in subjects. In particular, the subject may be candidates for treatment with one or more small molecule anti-diabetic drugs and the therapy may include implanting a population of pancreatic endocrine progenitor cells into the subject, where the cells are allowed to mature in vivo to produce a population.
    Type: Grant
    Filed: March 11, 2016
    Date of Patent: September 15, 2020
    Assignee: CCS VENTURES LIMITED
    Inventors: Timothy J. Kieffer, Jennifer E. Bruin
  • Pancreatic Endocrine Progenitor Cell Therapies for the Treatment of Obesity and Type 2 Diabetes (T2D)
    Publication number: 20180055890
    Abstract: Provided herein are therapies, and methods using that therapy, in the treatment of one or more of Type 2 diabetes (T2D), obesity, glucose intolerance and insulin resistance or to control weight gain in subjects. In particular, the subject may be candidates for treatment with one or more small molecule anti-diabetic drugs and the therapy may include implanting a population of pancreatic endocrine progenitor cells into the subject, where the cells are allowed to mature in vivo to produce a population.
    Type: Application
    Filed: March 11, 2016
    Publication date: March 1, 2018
    Inventors: Timothy J. Kieffer, Jennifer E. Bruin